Flavonoids of galing plants (Cayratia trifolia Linn) in animal model of breast cancer: Analysis of COX-2, cyclin D1 and wild type p53

Eva Pravitasari Nefertiti, I. Ketut Sudiana, Endang Joewarini, Titut Harnanik, Tedy Juliandhy

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)

Abstract

Background: To investigate the effect of flavonoids extract from Galing plants (Cayratia trifolia Linn) in animal model of breast cancer through changes in the expression of COX-2, cyclin D1 and wild type p53. Methods: 24 adult female Wistar strain white rats (Rattus norvegicus). Rats were divided into three groups, normal rats-non flavonoids from Galing plants extract as the normal group (G1), breast cancer rats-non flavonoids from Galing plants extractas the control group (G2) and breast cancer rats-flavonoids from Galing plants extractas the treatment group (G3). Histological examination of rat breast tissue was assessed by expression of COX-2, cyclin D1 and wild type p53 were measured by immuno-histochemistry technique. The volume of breast cancer was measured by a measuring cup. Results: There were significant decrease (p < 0.05) in the expression of the COX-2, cyclin D1 and volume of breast cancer in the G3 group compared to G2 group. The expression of wild type p53 increased significantly (p < 0.05) in the G3 group compared to G2 group . Conclusion: Flavonoids from Galing plants (Cayratia trifolia Linn) extract can be recommended to support therapy for breast cancer.

Original languageEnglish
Pages (from-to)459-463
Number of pages5
JournalInternational Medical Journal
Volume27
Issue number4
Publication statusPublished - Aug 2020

Keywords

  • Breast cancer
  • COX-2
  • Cyclin D1
  • Flavonoid of galing extract
  • P53 (wild type)

Fingerprint

Dive into the research topics of 'Flavonoids of galing plants (Cayratia trifolia Linn) in animal model of breast cancer: Analysis of COX-2, cyclin D1 and wild type p53'. Together they form a unique fingerprint.

Cite this